Related references
Note: Only part of the references are listed.Recent developments of RET protein kinase inhibitors with diverse scaffolds as hinge binders
Cong-Cong Jia et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors
Swapnil P. Bhujbal et al.
MOLECULES (2021)
Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics
Shraddha Parate et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics
Shraddha Parate et al.
MOLECULES (2021)
Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
Shraddha Parate et al.
PHARMACEUTICALS (2021)
PubChem in 2021: new data content and improved web interfaces
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2021)
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
Aswini Krishnan et al.
NATURE COMMUNICATIONS (2020)
Targeting RET Kinase in Neuroendocrine Prostate Cancer
Halena R. VanDeusen et al.
MOLECULAR CANCER RESEARCH (2020)
Application of MM-PBSA Methods in Virtual Screening
Giulio Poli et al.
MOLECULES (2020)
Glioblastomas harboring gene fusions detected by next-generation sequencing
Ha Young Woo et al.
BRAIN TUMOR PATHOLOGY (2020)
RET overactivation leads to concurrent Hirschsprung disease and intestinal ganglioneuromas
Nandor Nagy et al.
DEVELOPMENT (2020)
RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer
Arun Kumar Mahato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Exploring the computational methods for protein-ligand binding site prediction
Jingtian Zhao et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Receptor-guided 3D-QSAR Study of Anilinoquinazolines as RET Receptor Tyrosine Kinase Antagonists
Swapnil Pandurang Bhujbal et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2019)
Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions
Christoph Jakob Ackermann et al.
ONCOTARGETS AND THERAPY (2019)
RET, a targetable driver of pancreatic adenocarcinoma
Moran Amit et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A primer on the genetics of medullary thyroid cancer
V. Larouche et al.
CURRENT ONCOLOGY (2019)
Structure and function of RET in multiple endocrine neoplasia type 2
Ivan Plaza-Menacho
ENDOCRINE-RELATED CANCER (2018)
Molecular dynamics simulations and novel drug discovery
Xuewei Liu et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes
Alexander Drilon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
RET-fusions: a novel paradigm in colorectal cancer
C. Santos et al.
ANNALS OF ONCOLOGY (2018)
Selective RET kinase inhibition for patients with RET-altered cancers
V. Subbiah et al.
ANNALS OF ONCOLOGY (2018)
Protein structure-based drug design: from docking to molecular dynamics
Pawel Sledz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors
Valeria La Pietra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers
Robert Roskoski et al.
PHARMACOLOGICAL RESEARCH (2018)
RET rearrangements are actionable alterations in breast cancer
Bhavna S. Paratala et al.
NATURE COMMUNICATIONS (2018)
Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC
Ibiayi Dagogo-Jack et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
In silico studies on 2-substituted phenol quinazoline derivatives as RET receptor tyrosine kinase antagonists
Swapnil P. Bhujbal et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Mechanisms of RET signaling in cancer: Current and future implications for targeted therapy
I. Plaza-Menacho et al.
CELLULAR SIGNALLING (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach
C. George Priya Doss et al.
MOLECULAR BIOSYSTEMS (2014)
Multiple Functional Effects of RET Kinase Domain Sequence Variants in Hirschsprung Disease
Brandy D. Hyndman et al.
HUMAN MUTATION (2013)
Cellular Signaling Pathway Alterations and Potential Targeted Therapies for Medullary Thyroid Carcinoma
Serena Giunti et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
Structure and Physiology of the RET Receptor Tyrosine Kinase
Carlos F. Ibanez
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Protein-Ligand-Based Pharmacophores: Generation and Utility Assessment in Computational Ligand Profiling
Jamel Meslamani et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Multiple Endocrine Neoplasias Type 2B and RET proto-oncogene
Giuseppe Martucciello et al.
ITALIAN JOURNAL OF PEDIATRICS (2012)
Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors
Kuei-Chung Shih et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
New Features that Improve the Pharmacophore Tools from Accelrys
Jon Sutter et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2011)
SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules
Vincent Zoete et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Pharmacophore Modeling in drug discovery and development: An overview
Santosh A. Khedkar et al.
MEDICINAL CHEMISTRY (2007)
Canonical sampling through velocity rescaling
Giovanni Bussi et al.
JOURNAL OF CHEMICAL PHYSICS (2007)
Structure and chemical inhibition of the RET tyrosine kinase domain
Phillip P. Knowles et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors
F Carlomagno et al.
ONCOGENE (2004)
Improved protein-ligand docking using GOLD
ML Verdonk et al.
PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)
Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET
S Kjær et al.
HUMAN MOLECULAR GENETICS (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
